Cargando…

AXL-Receptor Targeted 14FN3 Based Single Domain Proteins (Pronectins™) from 3 Synthetic Human Libraries as Components for Exploring Novel Bispecific Constructs against Solid Tumors

A highly specific AXL-receptor targeted family of non-immunoglobulin, single domain protein binders (Pronectins™) have been isolated from three (3) synthetic libraries that employ the human scaffold of the 14th domain of Fibronectin III (14FN3) and evolutionary CDRs diversity of over 25 billion loop...

Descripción completa

Detalles Bibliográficos
Autores principales: Hokanson, Craig A., Zacco, Emanuela, Cappuccilli, Guido, Odineca, Tatjana, Crea, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775294/
https://www.ncbi.nlm.nih.gov/pubmed/36551940
http://dx.doi.org/10.3390/biomedicines10123184
_version_ 1784855609012649984
author Hokanson, Craig A.
Zacco, Emanuela
Cappuccilli, Guido
Odineca, Tatjana
Crea, Roberto
author_facet Hokanson, Craig A.
Zacco, Emanuela
Cappuccilli, Guido
Odineca, Tatjana
Crea, Roberto
author_sort Hokanson, Craig A.
collection PubMed
description A highly specific AXL-receptor targeted family of non-immunoglobulin, single domain protein binders (Pronectins™) have been isolated from three (3) synthetic libraries that employ the human scaffold of the 14th domain of Fibronectin III (14FN3) and evolutionary CDRs diversity of over 25 billion loop sequences. The three libraries, each containing diversity in two loops, were designed to expand upon a human database of more than 6000 natural scaffold sequences and approximately 3000 human loop sequences. We used a bioinformatic-based approach to maximize “human” amino acid loop diversity and minimize or prevent altogether CDR immunogenicity created by the use of mutagenesis processes to generate diversity. A combination of phage display and yeast display was used to isolate 59 AXL receptor targeted Pronectins with KD ranging between 2 and 100 nM. FACS analysis with tumor cells over-expressing AXL and the use of an AXL knock-out cell line allowed us to identify Pronectin candidates with exquisite specificity for AXL receptor. Based upon several in vitro cell-based tests, we selected the best candidate, AXL54, to further characterize its in vitro cancer cells killing activity. Finally, AXL54 was used to produce the first bi-specific T cell engager protein (AXL54 [Pronectin]-linker-scFV CD3), a “new in class” protein for further testing of its anti-tumor activity in vitro and in vivo.
format Online
Article
Text
id pubmed-9775294
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97752942022-12-23 AXL-Receptor Targeted 14FN3 Based Single Domain Proteins (Pronectins™) from 3 Synthetic Human Libraries as Components for Exploring Novel Bispecific Constructs against Solid Tumors Hokanson, Craig A. Zacco, Emanuela Cappuccilli, Guido Odineca, Tatjana Crea, Roberto Biomedicines Article A highly specific AXL-receptor targeted family of non-immunoglobulin, single domain protein binders (Pronectins™) have been isolated from three (3) synthetic libraries that employ the human scaffold of the 14th domain of Fibronectin III (14FN3) and evolutionary CDRs diversity of over 25 billion loop sequences. The three libraries, each containing diversity in two loops, were designed to expand upon a human database of more than 6000 natural scaffold sequences and approximately 3000 human loop sequences. We used a bioinformatic-based approach to maximize “human” amino acid loop diversity and minimize or prevent altogether CDR immunogenicity created by the use of mutagenesis processes to generate diversity. A combination of phage display and yeast display was used to isolate 59 AXL receptor targeted Pronectins with KD ranging between 2 and 100 nM. FACS analysis with tumor cells over-expressing AXL and the use of an AXL knock-out cell line allowed us to identify Pronectin candidates with exquisite specificity for AXL receptor. Based upon several in vitro cell-based tests, we selected the best candidate, AXL54, to further characterize its in vitro cancer cells killing activity. Finally, AXL54 was used to produce the first bi-specific T cell engager protein (AXL54 [Pronectin]-linker-scFV CD3), a “new in class” protein for further testing of its anti-tumor activity in vitro and in vivo. MDPI 2022-12-08 /pmc/articles/PMC9775294/ /pubmed/36551940 http://dx.doi.org/10.3390/biomedicines10123184 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hokanson, Craig A.
Zacco, Emanuela
Cappuccilli, Guido
Odineca, Tatjana
Crea, Roberto
AXL-Receptor Targeted 14FN3 Based Single Domain Proteins (Pronectins™) from 3 Synthetic Human Libraries as Components for Exploring Novel Bispecific Constructs against Solid Tumors
title AXL-Receptor Targeted 14FN3 Based Single Domain Proteins (Pronectins™) from 3 Synthetic Human Libraries as Components for Exploring Novel Bispecific Constructs against Solid Tumors
title_full AXL-Receptor Targeted 14FN3 Based Single Domain Proteins (Pronectins™) from 3 Synthetic Human Libraries as Components for Exploring Novel Bispecific Constructs against Solid Tumors
title_fullStr AXL-Receptor Targeted 14FN3 Based Single Domain Proteins (Pronectins™) from 3 Synthetic Human Libraries as Components for Exploring Novel Bispecific Constructs against Solid Tumors
title_full_unstemmed AXL-Receptor Targeted 14FN3 Based Single Domain Proteins (Pronectins™) from 3 Synthetic Human Libraries as Components for Exploring Novel Bispecific Constructs against Solid Tumors
title_short AXL-Receptor Targeted 14FN3 Based Single Domain Proteins (Pronectins™) from 3 Synthetic Human Libraries as Components for Exploring Novel Bispecific Constructs against Solid Tumors
title_sort axl-receptor targeted 14fn3 based single domain proteins (pronectins™) from 3 synthetic human libraries as components for exploring novel bispecific constructs against solid tumors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775294/
https://www.ncbi.nlm.nih.gov/pubmed/36551940
http://dx.doi.org/10.3390/biomedicines10123184
work_keys_str_mv AT hokansoncraiga axlreceptortargeted14fn3basedsingledomainproteinspronectinsfrom3synthetichumanlibrariesascomponentsforexploringnovelbispecificconstructsagainstsolidtumors
AT zaccoemanuela axlreceptortargeted14fn3basedsingledomainproteinspronectinsfrom3synthetichumanlibrariesascomponentsforexploringnovelbispecificconstructsagainstsolidtumors
AT cappuccilliguido axlreceptortargeted14fn3basedsingledomainproteinspronectinsfrom3synthetichumanlibrariesascomponentsforexploringnovelbispecificconstructsagainstsolidtumors
AT odinecatatjana axlreceptortargeted14fn3basedsingledomainproteinspronectinsfrom3synthetichumanlibrariesascomponentsforexploringnovelbispecificconstructsagainstsolidtumors
AT crearoberto axlreceptortargeted14fn3basedsingledomainproteinspronectinsfrom3synthetichumanlibrariesascomponentsforexploringnovelbispecificconstructsagainstsolidtumors